We entered into a special agreement with the National University Corporation, the University of Tokyo (hereinafter referred to as “the University of Tokyo”), in 2021. Since the conclusion of this agreement, we have been collaborating with research institutions and laboratories affiliated with the University of Tokyo to advance the development of next-generation cutting-edge technologies.
We are pleased to announce the commencement of an innovative industry-academia collaborative project with the Institute of Medical Science of the University of Tokyo. As the first initiative, we will engage in comprehensive collaboration and cooperation in the vaccine research analysis conducted by the Institute of Medical Science of the University of Tokyo.
Regarding further details, we will provide additional information in a press release once we have obtained approval from the relevant parties.